cetyltrimethylammonium ion has been researched along with Triple Negative Breast Neoplasms in 2 studies
Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imanparast, A | 1 |
| Shaegh, SAM | 1 |
| Attaran, N | 1 |
| Ameri, AR | 1 |
| Sazgarnia, A | 1 |
| Meena, R | 1 |
| Kumar, S | 1 |
| Kumar, R | 1 |
| Gaharwar, US | 1 |
| Rajamani, P | 1 |
2 other studies available for cetyltrimethylammonium ion and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Opto-microfluidic assisted synthesis of photo-protoporphyrin (pPP) conjugated to hollow gold-albumin hybrid nanoshells to enhance the efficiency of photodynamic therapy of triple negative breast cancer cells.
Topics: Cell Line, Tumor; Cetrimonium; Gold; Humans; Microfluidics; Nanoshells; Photochemotherapy; Photosens | 2023 |
PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cetrimonium; Cetrimonium Compounds; | 2017 |